Brendan Prideaux

Brendan Prideaux, PhD is an Assistant Professor in the Department of Neurobiology at the University of Texas Medical Branch (UTMB). His research focuses on applying Mass Spectrometry Imaging (MSI) to study infectious disease pathogenesis.

Education:

• PhD in Biomedical Chemistry from Sheffield Hallam University, UK (2003-2007)
• BSc (Hons) in Biomedical Chemistry from Sheffield Hallam University, UK (1999-2003)

Research Interests center on understanding host-pathogen interactions at cellular resolution through label-free MALDI-MSI technology. He investigates spatial molecular distributions in diseases like HIV, Tuberculosis, Cerebral Malaria, and Cancer Metastasis, with applications in Lipidomics and Drug Development.

Article Trends show consistent focus on spatial quantification of therapeutic compounds in infectious lesions and oncological tissues. Key methodologies include MALDI-MSI, LCM-LC/MS, and PGC1α-Lipin1 pathway analysis.

Technical Expertise spans imaging mass spectrometry, pharmaceutical bioanalysis, and multi-scale systems pharmacology. His work bridges Neurobiology, Microbiology, and Clinical Pharmacology through innovative drug distribution mapping approaches.